A Randomized, Double Blind, Placebo-Controlled, Multicenter Phase II Trial of Allisartan Isoproxil in Essential Hypertensive Population at Low-Medium Risk

por Li, Ying, Li, Xiao-hui, Huang, Zhi-jun, Yang, Guo-ping, Zhang, Guo-gang, Zhao, Shui-ping, Guo, Ying, Lu, Shi-juan, Ma, Jian-lin, Meng, Fan-bo, Chen, Ping, Yuan, Hong
Publicado 2015